ZA974271B - A method of treating asthma - Google Patents

A method of treating asthma

Info

Publication number
ZA974271B
ZA974271B ZA974271A ZA974271A ZA974271B ZA 974271 B ZA974271 B ZA 974271B ZA 974271 A ZA974271 A ZA 974271A ZA 974271 A ZA974271 A ZA 974271A ZA 974271 B ZA974271 B ZA 974271B
Authority
ZA
South Africa
Prior art keywords
treating asthma
asthma
treating
Prior art date
Application number
ZA974271A
Other languages
English (en)
Inventor
Alison Mary Badger
John Gerald Gleason
Original Assignee
Anormed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anormed Inc filed Critical Anormed Inc
Publication of ZA974271B publication Critical patent/ZA974271B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
ZA974271A 1996-05-17 1997-05-16 A method of treating asthma ZA974271B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1788996P 1996-05-17 1996-05-17

Publications (1)

Publication Number Publication Date
ZA974271B true ZA974271B (en) 1998-08-25

Family

ID=21785110

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA974271A ZA974271B (en) 1996-05-17 1997-05-16 A method of treating asthma

Country Status (17)

Country Link
US (1) US6025364A (cs)
EP (1) EP0910373A1 (cs)
JP (1) JP2000513335A (cs)
KR (1) KR20000010933A (cs)
CN (1) CN1219129A (cs)
AU (1) AU710542B2 (cs)
BR (1) BR9709007A (cs)
CA (1) CA2253217A1 (cs)
CZ (1) CZ367598A3 (cs)
HU (1) HUP0003908A3 (cs)
IL (1) IL127040A0 (cs)
NO (1) NO985325L (cs)
NZ (1) NZ332627A (cs)
PL (1) PL329931A1 (cs)
SK (1) SK156698A3 (cs)
WO (1) WO1997044030A1 (cs)
ZA (1) ZA974271B (cs)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2518357A1 (en) * 2003-03-10 2004-09-23 Callisto Pharmaceuticals, Inc. Method of treating cancer with azaspirane compositions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4963557A (en) * 1987-09-28 1990-10-16 Smithkline Beecham Corporation Immunomodulatory azaspiranes
AU652583B2 (en) * 1990-09-24 1994-09-01 Smithkline Beecham Corporation Methods
ZA921120B (en) * 1991-02-19 1993-01-27 Smithkline Beecham Corp Cytokine inhibitors
US5482959A (en) * 1992-01-28 1996-01-09 Smithkline Beecham Corporation Method for delaying aids in an HIV infected individual by administration of substituted azaspirane compounds
GB9315306D0 (en) * 1993-07-23 1993-09-08 Smithkline Beecham Corp Methods
GB9315340D0 (en) * 1993-07-23 1993-09-08 Smithkline Beecham Corp Methods
GB9315351D0 (en) * 1993-07-23 1993-09-08 Smithkline Beecham Corp Methods

Also Published As

Publication number Publication date
EP0910373A1 (en) 1999-04-28
NZ332627A (en) 2001-06-29
CA2253217A1 (en) 1997-11-27
KR20000010933A (ko) 2000-02-25
AU710542B2 (en) 1999-09-23
NO985325D0 (no) 1998-11-16
HUP0003908A2 (en) 2001-03-28
HUP0003908A3 (en) 2001-04-28
NO985325L (no) 1998-11-16
CZ367598A3 (cs) 1999-05-12
SK156698A3 (en) 1999-06-11
CN1219129A (zh) 1999-06-09
PL329931A1 (en) 1999-04-26
AU2973997A (en) 1997-12-09
JP2000513335A (ja) 2000-10-10
IL127040A0 (en) 1999-09-22
BR9709007A (pt) 2000-01-04
WO1997044030A1 (en) 1997-11-27
US6025364A (en) 2000-02-15

Similar Documents

Publication Publication Date Title
EP0906099A4 (en) CANCER TREATMENT METHOD
PL321426A1 (en) Method of enzymaticaly treating wool
IL123166A0 (en) Method and composition for treating asthma
EP0771203A4 (en) PROCESS FOR TREATING PATHOLOGIES ASSOCIATED WITH BREATHING
EP0973396A4 (en) METHOD FOR TREATING CANCER
GB9801231D0 (en) A method of treating cancer
ZA977564B (en) Method of treatment
EP0691674A3 (en) Method for producing micro-drawings
IL112381A0 (en) A method of treating glaucoma
GB9620412D0 (en) A method of treating a laminate
ZA9710294B (en) Method of treating atherosclerosis
PL332903A1 (en) Method of treating a carbonaceous material
GB2340775B (en) Method of treating a surface
IL127747A0 (en) Method of treating a plant disease
ZA973988B (en) Method of treatment
GB9618341D0 (en) Method of treatment
ZA974271B (en) A method of treating asthma
PL329476A1 (en) Method of treating sleeplessness
GB2294880B (en) Method of treating turf
EP0755437A4 (en) A METHOD FOR TRANSFORMING NOCARDIA
GB9415902D0 (en) Method of treatment
GB2293748B (en) A process of treating tobacco
GB9401402D0 (en) New method of treating dyslipidemias
GB9407335D0 (en) Method of treatment
EP1019529A4 (en) METHOD FOR TREATING CANCER